Macrolide-resistant Bordetella pertussis strain identified in Finland
Author Information
Author(s): Miettinen Milja, Barkoff Alex-Mikael, Nyqvist Aino, Savolainen-Kopra Carita, Antikainen Jenni, Mertsola Jussi, Ivaska Lauri, He Qiushui
Primary Institution: Finnish Reference Laboratory for Diphtheria and Pertussis, University of Turku
Hypothesis
The study investigates the emergence of macrolide-resistant Bordetella pertussis during an ongoing epidemic in Finland.
Conclusion
The study identified the first macrolide-resistant Bordetella pertussis isolate in Finland, highlighting the need for rapid detection and surveillance.
Supporting Evidence
- There were 2,215 notified cases of pertussis in Finland from January to October 2024.
- 30.1% of the cases were in adolescents aged 10-14 years.
- One Bordetella pertussis isolate was found to be macrolide-resistant with a minimum inhibitory concentration greater than 256 μg/mL.
Takeaway
There is a new type of whooping cough bacteria in Finland that doesn't respond to some common medicines, and it's important to find it quickly.
Methodology
The study involved characterizing Bordetella pertussis isolates from an ongoing epidemic and testing for macrolide resistance using Etest and PCR methods.
Limitations
The study lacks clinical information about the patient from whom the resistant isolate was obtained.
Participant Demographics
The majority of cases were among adolescents aged 10-14 years, with a notable number of cases in younger children and infants.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website